Related Experiment Videos
Protective Plasmodium knowlesi Mr 74,000 antigen in membranes of schizont-infected rhesus erythrocytes
Abstract:
The immunogenic Plasmodium knowlesi (H strain) Mr 74,000 protein in membranes of schizont-infected rhesus erythrocytes was purified on a large scale, free of other polypeptides as monitored by dodecyl sulfate polyacrylamide gel electrophoresis and isoelectric focusing. In a limited vaccination trial, four rhesus monkeys were immunized four consecutive times with the Mr 74,000 protein and Freund's complete and incomplete adjuvants. Two monkeys were injected with adjuvant only. Upon challenge with 10(4) viable P. knowlesi schizonts of the heterologous W strain, the control monkeys developed fatal parasitemias after 7 d. In contrast, the vaccinated monkeys exhibited a delayed onset of patent parasitemias and underwent self-cure on days 14 to 16 after peak parasitemias of between 7 and 11%. The protective immunity that was induced crossed different strains of P. knowlesi. Blood smears at the time of cure demonstrated limited reinfection, as indicated by the presence of normally appearing ring and trophozoite stages. The absence of schizont stages in the peripheral blood suggested a specific interruption of the erythrocytic schizogony at that stage. Immunochemical analyses of the rhesus sera revealed antibody only against the Mr 74,000 protein after the first two immunizations. Upon repeated antigen injection, antibodies reacted with components of Mr of approximately 102,000, 140,000, and 230,000 in addition to the Mr 74,000 protein. Besides immunological cross-reactivity, relatedness between all four immune-precipitated proteins was indicated by a greater than 50% tryptic peptide homology, suggesting that the Mr 230,000 component represents a precursor protein that is cleaved within the infected erythrocyte into proteins with Mr of approximately 140,000, 102,000, and 74,000.
Insights
A purified Plasmodium knowlesi protein induced protective immunity in monkeys against malaria. This immunity delayed parasite growth and allowed self-cure, demonstrating potential for a Plasmodium knowlesi vaccine.
Area of Science:
- * Parasitology
- * Immunology
- * Vaccine Development
Background:
- * Plasmodium knowlesi is a significant cause of human malaria.
- * Identifying effective vaccine targets is crucial for malaria control.
Purpose of the Study:
- * To purify and characterize an immunogenic Plasmodium knowlesi protein.
- * To evaluate the protective efficacy of this protein in a rhesus monkey model.
- * To investigate the immune response elicited by the purified protein.
Main Methods:
- * Large-scale purification of the Mr 74,000 Plasmodium knowlesi protein.
- * Vaccination of rhesus monkeys with the purified protein and adjuvants.
- * Challenge with live Plasmodium knowlesi schizonts and monitoring of parasitemia.
- * Immunochemical analysis of serum antibodies and protein homology studies.
Main Results:
- * Vaccinated monkeys showed delayed parasitemia and self-cure, unlike control groups.
- * Induced immunity conferred protection against a heterologous strain of Plasmodium knowlesi.
- * Antibodies recognized multiple related proteins, suggesting a precursor-product relationship.
Conclusions:
- * The Mr 74,000 Plasmodium knowlesi protein is a promising candidate for malaria vaccine development.
- * The induced immunity specifically targets erythrocytic schizogony.
- * Further research into the identified protein family may reveal additional vaccine targets.